CO46096: A Phase III , Randomized, Open-Label, Multicenter Study Evaluating The Efficacy and Safety of Cevostamab in Combination with Pomalidomide and Dexamethasone vs SOC in Patients with Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
- Title
- A Phase III , Randomized, Open-Label, Multicenter Study Evaluating The Efficacy and Safety of Cevostamab in Combination with Pomalidomide and Dexamethasone vs SOC in Patients with Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
- Principal Investigator
- Veltri, Lauren
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Kathryn Oliverio, LPN
- Research Specialist
- Phone: +1 304-293-7374
- Email: kathryn.oliverio1@hsc.wvu.edu